Vanderbilt researchers have developed a set of nanoparticles that stimulate the immune system in mice to fight cancer and may eventually do the same in humans. The research, led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, was recently published in ACS Nano.
